Swain, S. (2017) “2-hour 75 gm OGTT for screening and Rescreening at 32-34 weeks for diagnosing gestational diabetes-evaluation of maternal and neonatal outcomes”, International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 6(7), pp. 2926–2932. doi: 10.18203/2320-1770.ijrcog20172909.